Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Carly C Barron"'
Autor:
Elaine McWhirter, Carly C Barron, Isabella Stefanova, Yevin Cha, Karam Elsolh, Arman Zereshkian, Nessma Gaafour
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Immune-related adverse events (irAEs) are toxicities resulting from use of immune checkpoint inhibitors (ICIs). These side effects persist in some patients despite withholding therapy and using immunosuppressive and immune-modulating agents. Little i
Externí odkaz:
https://doaj.org/article/adc1efacb7cc4521912cffa0aa1f3182
Autor:
Darryl P. Leong, MBBS, MPH, MBiostat, PhD, Tammy Cosman, PhD, Muhammad M. Alhussein, MD, Nidhi Kumar Tyagi, MBChB, Sarah Karampatos, MS, Carly C. Barron, MD, MS, Douglas Wright, MD, Vikas Tandon, MD, Patrick Magloire, MD, Philip Joseph, MD, David Conen, MD, MPH, P.J. Devereaux, MD, PhD, Peter M. Ellis, MBBS, MMed, PhD, Som D. Mukherjee, MD, MS, Sukhbinder Dhesy-Thind, MD, MS
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 1, Pp 1-10 (2019)
Objectives: This study sought to evaluate the safety of continuing trastuzumab in patients with human epidermal growth factor receptor–positive breast cancer who developed mild cardiotoxicity. Background: Cardiotoxicity is the most common dose-limi
Externí odkaz:
https://doaj.org/article/853ece99bece43b0bf1ea0e673d30148
Publikováno v:
Thoracic Surgery Clinics. 33:197-208
Autor:
Carly C. Barron, Manoj M. Lalu, Duncan J. Stewart, Dean Fergusson, Homer Yang, David Moher, Peter Liu, David Mazer, P. J. Devereaux, Lauralyn McIntyre, On Behalf of the Canadian Perioperative Anesthesia Clinical Trials Group
Publikováno v:
Systematic Reviews, Vol 6, Iss 1, Pp 1-8 (2017)
Abstract Background Despite advances in treatment, acute myocardial infarction (MI) is still associated with significant morbidity and mortality, especially in patients with extensive damage and scar formation. Based on some promising preclinical stu
Externí odkaz:
https://doaj.org/article/a148eba378d942b1a980d47948361bd5
Autor:
Mark B. Badrov, Katelyn N. Wood, Sophie Lalande, Carolyn P. Sawicki, Lindsay J. Borrell, Carly C. Barron, Jennifer L. Vording, Arlene Fleischhauer, Neville Suskin, Cheri L. McGowan, J. Kevin Shoemaker
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 17 (2019)
Background Autonomic dysregulation represents a hallmark of coronary artery disease (CAD). Therefore, we investigated the effects of exercise‐based cardiac rehabilitation (CR) on autonomic function and neuro‐cardiovascular stress reactivity in CA
Externí odkaz:
https://doaj.org/article/d026fd5a2add4b3b8429029bb82c3df0
Autor:
Dean A Fergusson, Marc T Avey, Carly C Barron, Mathew Bocock, Kristen E Biefer, Sylvain Boet, Stephane L Bourque, Isidora Conic, Kai Chen, Yuan Yi Dong, Grace M Fox, Ronald B George, Neil M Goldenberg, Ferrante S Gragasin, Prathiba Harsha, Patrick J Hong, Tyler E James, Sarah M Larrigan, Jenna L MacNeil, Courtney A Manuel, Sarah Maximos, David Mazer, Rohan Mittal, Ryan McGinn, Long H Nguyen, Abhilasha Patel, Philippe Richebé, Tarit K Saha, Benjamin E Steinberg, Sonja D Sampson, Duncan J Stewart, Summer Syed, Kimberly Vella, Neil L Wesch, Manoj M Lalu, Canadian Perioperative Anesthesia Clinical Trials Group
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0215221 (2019)
Poor reporting quality may contribute to irreproducibility of results and failed 'bench-to-bedside' translation. Consequently, guidelines have been developed to improve the complete and transparent reporting of in vivo preclinical studies. To examine
Externí odkaz:
https://doaj.org/article/a41cd83c1ab14abfbdd7bdf3fab9263c
Autor:
Thais Baccili Cury Megid, Divya Sharma, Lucy Xiaolu Ma, Xin Wang, Carly C. Barron, Raymond Woo-Jun Jang, Carol Jane Swallow, Aruz Mesci, Jonathan Yeung, Rebecca KS Wong, Eric Xueyu Chen, Savtaj Singh Brar, Patrick Veit-Haibach, John Kim, Yvonne Bach, Hiroko Aoyama, Elena Elimova
Publikováno v:
Journal of Clinical Oncology. 41:320-320
320 Background: Patient reported outcomes (PRO) measures are accurate self-reflections of an individual’s physical functioning and emotional well-being. The prognostic value is unknown in gastroesophageal (GE) cancer patients (pts). The Edmonton Sy
Autor:
Xin Wang, Osvaldo Espin-Garcia, Yvonne Bach, Hiroko Aoyama, Lucy Xiaolu Ma, Carly C. Barron, Thais Baccili Cury Megid, Eric Xueyu Chen, Jonathan Yeung, Carol Jane Swallow, Savtaj Singh Brar, Rebecca KS Wong, Aruz Mesci, John Kim, Patrick Veit-Haibach, Sangeetha Kalimuthu, Raymond Woo-Jun Jang, Elena Elimova
Publikováno v:
Journal of Clinical Oncology. 41:302-302
302 Background: The majority of esophageal and gastric cancers are diagnosed at an advanced stage with poor overall survival (OS), leading some to propose screening, even in countries with a low incidence. Whether diagnostic delay from symptom onset
Autor:
Tammy Cosman, Darryl P. Leong, Peter M. Ellis, Douglas Wright, Vikas Tandon, David Conen, Philip J. Devereaux, Nidhi Kumar Tyagi, Carly C. Barron, Philip Joseph, Patrick Magloire, Som D. Mukherjee, Sarah Karampatos, Muhammad Mustafa Alhussein, Sukhbinder Dhesy-Thind
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 1, Pp 1-10 (2019)
JACC: CardioOncology
JACC: CardioOncology
Objectives This study sought to evaluate the safety of continuing trastuzumab in patients with human epidermal growth factor receptor–positive breast cancer who developed mild cardiotoxicity. Background Cardiotoxicity is the most common dose-limiti
Autor:
Mark Brown, U Kaur, Darryl P. Leong, Nidhi Kumar Tyagi, Muhammad Mustafa Alhussein, Som D. Mukherjee, Tammy Cosman, Sukhbinder Dhesy-Thind, Carly C. Barron, Peter M. Ellis
Publikováno v:
Current Oncology
Volume 26
Issue 4
Pages 4631-246
Volume 26
Issue 4
Pages 4631-246
The major limitation in the use of trastuzumab therapy is cardiotoxicity. We evaluated the safety of a strategy of continuing trastuzumab in patients with breast cancer despite mild, asymptomatic left ventricular impairment. Charts of consecutive pat